niacinamide has been researched along with Gastric Ulcer in 11 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Excerpt | Relevance | Reference |
---|---|---|
" The present study was conducted to test for the possible gastroprotective effect of nicotinamide utilizing an acute indomethacin-induced gastric ulcer model." | 7.76 | Nicotinamide alleviates indomethacin-induced gastric ulcers: a novel antiulcer agent. ( Abdallah, DM, 2010) |
"Candida esophagitis was suspected." | 5.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
" The present study was conducted to test for the possible gastroprotective effect of nicotinamide utilizing an acute indomethacin-induced gastric ulcer model." | 3.76 | Nicotinamide alleviates indomethacin-induced gastric ulcers: a novel antiulcer agent. ( Abdallah, DM, 2010) |
" Solid dispersion capsule PNC1 (containing 1:5--drug-carrier ratio solid dispersion) and the corresponding physical mixture capsule PNC1A were used for bioavailability studies in healthy human volunteers." | 2.71 | Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations. ( Balasubramaniam, J; Kumar, MT; Pandit, JK; Verma, MM, 2003) |
"Candida esophagitis was suspected." | 1.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
" The incidence of SBI (Common Terminology Criteria for Adverse Events, version 4." | 1.39 | Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). ( Barney, BM; Bauer, HJ; Laack, NN; Macdonald, OK; Markovic, SN; Miller, RC; Olivier, KR; Sarkaria, JN, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barney, BM | 1 |
Markovic, SN | 1 |
Laack, NN | 1 |
Miller, RC | 1 |
Sarkaria, JN | 1 |
Macdonald, OK | 1 |
Bauer, HJ | 1 |
Olivier, KR | 1 |
Chen, KH | 1 |
Weng, MT | 1 |
Chou, YH | 1 |
Lu, YF | 1 |
Hsieh, CH | 1 |
Abdallah, DM | 1 |
Stupin, VA | 1 |
Siluianov, SV | 1 |
Smirnov, GO | 1 |
Sobirov, MA | 1 |
Pimple, BP | 1 |
Kadam, PV | 1 |
Patil, MJ | 1 |
Verma, MM | 1 |
Kumar, MT | 1 |
Balasubramaniam, J | 1 |
Pandit, JK | 1 |
Brzozowski, T | 1 |
Konturek, PC | 1 |
Chlopicki, S | 1 |
Sliwowski, Z | 1 |
Pawlik, M | 1 |
Ptak-Belowska, A | 1 |
Kwiecien, S | 1 |
Drozdowicz, D | 1 |
Pajdo, R | 1 |
Slonimska, E | 1 |
Konturek, SJ | 1 |
Pawlik, WW | 1 |
Oparin, AG | 1 |
Gazizov, RM | 1 |
Tanaka, H | 1 |
Naito, S | 1 |
Ivancho, ES | 1 |
Sabov, VA | 1 |
Dolgosh, SS | 1 |
Shchetka, MP | 1 |
Lindenbaum, ES | 1 |
Mueller, JJ | 1 |
1 trial available for niacinamide and Gastric Ulcer
Article | Year |
---|---|
Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential | 2003 |
10 other studies available for niacinamide and Gastric Ulcer
Article | Year |
---|---|
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antibodies, Monoclonal, H | 2013 |
Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candidiasis; Carcinoma, Hepatocel | 2016 |
Nicotinamide alleviates indomethacin-induced gastric ulcers: a novel antiulcer agent.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Capillary Permeability; Gastric Mucosa; Indomethacin; Male | 2010 |
[Current approaches to treating acute gastroduodenal ulcer bleedings].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; APACHE; Drug Combinations; Duodenal Ulcer; Fema | 2010 |
Protective effect of Luffa acutangula extracts on gastric ulceration in NIDDM rats: role of gastric mucosal glycoproteins and antioxidants.
Topics: Animals; Antioxidants; Aspirin; Biomarkers; Catalase; Diabetes Mellitus, Experimental; Dose-Response | 2012 |
Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves.
Topics: Acute Disease; Animals; Epoprostenol; Gastric Acid; Gastric Mucosa; Male; Neurons, Afferent; Niacina | 2008 |
[Effect of vitamin therapy on isoenzymatic activity in peptic ulcer of the stomach and duodenum].
Topics: Adolescent; Adult; Duodenal Ulcer; Enzyme Activation; Female; Humans; Isoenzymes; Male; Middle Aged; | 1976 |
[Studies on the biotransformation and anti-ulcer effects of 2-(nicotinoylaminoethanesulfonylamino)pyridine].
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Biotransformation; Injections, Intravenous; Kineti | 1985 |
[Vitamin metabolism in patients with ulcer disease and in postgastrectomy syndrome].
Topics: Ascorbic Acid; Female; Humans; Male; Niacinamide; Postgastrectomy Syndromes; Stomach Ulcer; Vitamin | 1973 |
Effects of pyridoxine on mice after immobilization stress.
Topics: Animals; Blood Glucose; Brain; Female; Immobilization; Mice; Niacinamide; Norepinephrine; Pyridoxine | 1974 |